Molecular Templates Inc (MTEM)
NASDAQ:MTEM

Molecular Templates (MTEM) Stock Investors

490 Followers
Based on 610,515 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold MTEM
On average, investors allocate 2.27% of their portfolios to MTEM
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 610,515 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding MTEM

0.9%
Last 7
Days
3.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding MTEM, out of 610,515 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

MTEM Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.01%
$0.35
Increased
2.06%
$0.36
Based on the activity of 11,659 investors who made their portfolios public
The table shows changes in MTEM in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

MTEM Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
General Electric
5.77%
-0.11%
+2.22%
$89.56B
Industrial Goods
Moderna
6.09%
+0.24%
+1.51%
$66.56B
Healthcare
Crispr Therapeutics AG
3.97%
-0.01%
-0.53%
$4.33B
Healthcare
Gilead Sciences
4.33%
-0.29%
-0.72%
$105.98B
Healthcare
Bristol Myers
4.07%
+0.31%
+0.81%
$158.29B
Healthcare
Syros Pharmaceuticals
3.88%
-0.65%
-4.28%
$102.14M
Healthcare
Tilray
4.82%
-0.13%
-0.86%
$1.97B
Basic Materials
Zoom Video Communications
3.39%
-0.51%
-1.79%
$23.25B
Technology
Virgin Galactic Holdings
4.40%
-0.65%
-0.73%
$1.67B
Technology
Teladoc
3.25%
-0.35%
-0.57%
$5.09B
Healthcare
Based on the activity of 610,515 active portfolios
Open your Smart Portfolio

MTEM Investor Analysis

MTEM investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
14.3%
of MTEM holders
are under 35
Average Segment Performance
Average P/E Ratio1.83
Beta4.80
Dividend Yield5.23%
MTEM investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
54.5%
of MTEM holders
are between 35–55
Average Segment Performance
Average P/E Ratio0.49
Beta1.09
Dividend Yield5.04%
MTEM investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
31.2%
of MTEM holders
are over 55
Average Segment Performance
Average P/E Ratio0.75
Beta1.00
Dividend Yield4.33%
Overview of age group and performance of MTEM stock investors
See who invests in MTEM according to age group and performance.

FAQ

How many retail Investors hold MTEM?
<0.1% of TipRank’s retail investors hold MTEM in their portfolios.
    What is MTEM Investor Sentiment?
    MTEM’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of MTEM in the last 7 days?
      ▼ 0.9% of TipRank’s retail investors changed their holding of MTEM in the last 7 days.
        What percentage of retail investors changed their holding of MTEM in the last 30 days?
        ▼ 3.2% of TipRank’s retail investors changed their holding of MTEM in the last 30 days.
          What is the average age of retail investors who hold MTEM?
          The average age of MTEM Holders is between 35–55.
            What other stocks have MTEM investors also bought?
            MTEM Investors also bought GE, MRNA, CRSP, GILD, BMY, SYRS, TLRY, ZM, SPCE, TDOC.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AAgilent
              ALGNAlign Tech
              ALNYAlnylam Pharma
              AMRNAmarin
              BAXBaxter International

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis